DGWA - **C CEO Roundtable: Biotech breakthroughs across Australia and Germany
30:45 - What is Australias perspective on the biotech ecosystem in Europe?
James Graham at 33:40
41:55 - How easy is it to conduct trials in Germany or other European countries compared to the US and Australia?
James Graham at 46:20
47:25 - What are the advantages and disadvantages of dual listing?
James Graham at 47:58
52:30 - Why Frankfurt, rather than Nasdaq?
James Graham at 56:02
DGWA - **C CEO Roundtable: Biotech breakthroughs across...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.0¢ |
Change
-0.005(1.03%) |
Mkt cap ! $111.1M | |||
| Open | High | Low | Value | Volume |
| 48.5¢ | 48.5¢ | 48.0¢ | $664 | 1.371K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 16579 | 47.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.5¢ | 2353 | 2 |
View Market Depth
| Last trade - 13.10pm 16/08/2024 (20 minute delay) ? |
| RCE (ASX) Chart |